Table:
begin	end	state
1	35	cytoplasmic
36	52	transmembrane
53	59	non-cytoplasmic
60	82	transmembrane
83	93	cytoplasmic
94	114	transmembrane
115	119	non-cytoplasmic
120	145	transmembrane
146	158	cytoplasmic
159	183	transmembrane
184	193	non-cytoplasmic
194	213	transmembrane
214	244	cytoplasmic
245	265	transmembrane
266	283	non-cytoplasmic
284	305	transmembrane
306	313	cytoplasmic
314	333	transmembrane
334	338	non-cytoplasmic
339	361	transmembrane
362	376	cytoplasmic
377	395	transmembrane
396	405	non-cytoplasmic
406	425	transmembrane
426	437	cytoplasmic

Input:
>GFF4482 FitnessBrowser__WCS417:GFF4482
MSTTYNEAAPAAAPTNSTARVATASIVGTAIEFYDFYIYATAAALVIGPVFFPQTSGTAQ
MLASFLTFGIAFIARPLGSALFGHFGDRIGRKSTLVASLLLMGVCTTLIGLLPGYDSIGA
WAPILLCVLRFGQGLGLGGEWGGAALLATENAPKGKRAWFGMFPQLGPSIGFLAANGLFL
ILAMSLSDEQFRSWGWRIPFILSAALVMVGLYARLKLHETPVFANAVAKEAPVKVPLVEL
FSQHWLPVLLGAASMVVCYALFYITTAFSLSYGVSTLGYSRETFLGLLCFAVLFMGLATP
LAALASDRFGRKPVLIVGALLAILSGFTMEPLLTHGSTWAVALFLALELFLMGVTFAPMG
AMLPELFPTRVRYTGASAAYNLGGIVGASAAPFFATKLVAMGGLSYVGGYVSAAALLSLI
AVLCLKETRDNDLNKVA

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server